Migraine drug trial halted midway
Symptom relief
Terminated
This study tested an experimental drug called K-645 for people having a migraine attack. It aimed to see if the drug could stop pain and other bothersome symptoms better than a placebo. The trial was stopped early, so results are limited. About 134 adults with a history of migrai…
Phase: PHASE2 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC